NEW YORK, March 21 – Rolling out the latest in an array of recent partnerships, Lynx Therapeutics said Wednesday it had entered into a collaboration with UroGene of Evry, France to use Lynx’s Megasort gene expression technology to discover gene expression patterns associated with prostate cancer, benign prostatic hypertrophy, renal carcinoma, and bladder cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.